← Leaderboards
Alan Schumitzky
University Of Washington
$556,580
Attributed
$556,580
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$556,580 · 5
By mechanism
P41$556,580 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- King Kennard Holmes$42,208,763
- Carey Farquhar$27,772,472
- Heidi M. Crane$25,961,202
- Ann Cornwall Collier$29,777,747
- Shiu-Lok Hu$65,602,557
Others in their field
Top investigators on “Statistics /Biometry”
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$72,963,986
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Thomas R Fleming · University Of Washington$51,130,691
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Jeffrey P Krischer · University Of South Florida$38,040,597
Research focus
Statistics /BiometryBiomedical ResourceBioengineering /Biomedical EngineeringTechnology /TechniqueInfectionInflammationLymphatic SystemNeoplasm /CancerTransplantationAidsVirusEnvironmental ToxicologyHematologyImmunology
Grant awards (15)
APPLICATION OF POPULATION KINETICS TO ENVIRONMENTAL TOXICOKINETIC STUDIES$0
P41 · FY2002 · RR
CONCENTRATION EFFECTS OF CY METABOLITES IN HEMATOPOIETIC STEM CELL TRANSPLANT$0
P41 · FY2002 · RR
MODELING THEORY &DEVELOPMENT OF ALGORITHMS: POPULATION KINETICS$0
P41 · FY2002 · RR
DVMT OF PHARM RELATIONSHIPS FOR ANTIVIRAL CHEMOTHERAPY: HIV PROTEASE INHIBITOR$0
P41 · FY2002 · RR
APPLICATION OF POPULATION KINETICS IN CLINICAL PHARMACOLOGY STUDIES$0
P41 · FY2002 · RR
DVMT OF PHARM RELATIONSHIPS FOR ANTIVIRAL CHEMOTHERAPY: HIV PROTEASE INHIBITOR$0
P41 · FY2001 · RR
MODELING THEORY &DEVELOPMENT OF ALGORITHMS: POPULATION KINETICS$0
P41 · FY2001 · RR
APPLICATION OF POPULATION KINETICS IN CLINICAL PHARMACOLOGY STUDIES$0
P41 · FY2001 · RR
CONCENTRATION EFFECTS OF CY METABOLITES IN HEMATOPOIETIC STEM CELL TRANSPLANT$0
P41 · FY2001 · RR
APPLICATION OF POPULATION KINETICS TO ENVIRONMENTAL TOXICOKINETIC STUDIES$0
P41 · FY2001 · RR
MODELING THEORY &DEVELOPMENT OF ALGORITHMS: POPULATION KINETICS$111,316
P41 · FY2000 · RR
APPLICATION OF POPULATION KINETICS TO ENVIRONMENTAL TOXICOKINETIC STUDIES$111,316
P41 · FY2000 · RR
CONCENTRATION EFFECTS OF CY METABOLITES IN HEMATOPOIETIC STEM CELL TRANSPLANT$111,316
P41 · FY2000 · RR
DVMT OF PHARM RELATIONSHIPS FOR ANTIVIRAL CHEMOTHERAPY: HIV PROTEASE INHIBITOR$111,316
P41 · FY2000 · RR
APPLICATION OF POPULATION KINETICS IN CLINICAL PHARMACOLOGY STUDIES$111,316
P41 · FY2000 · RR